KPV is a tripeptide (Lysine-Proline-Valine) derived from the C-terminal of Alpha-Melanocyte-Stimulating Hormone (α-MSH). It contains the core anti-inflammatory activity of α-MSH in a minimal 3 amino acid sequence, making it highly stable, well-tolerated, and capable of oral delivery. Browse the full peptide library for related healing compounds.
KPV is notable for its extraordinarily potent anti-inflammatory effects, particularly in the gut and skin. For tissue healing, it stacks well with BPC-157. Studies have shown it activates melanocortin receptors (specifically MC1-R, MC3-R, and MC5-R) in immune cells, producing a powerful anti-inflammatory response without the side effects of corticosteroids.
KPV is gaining significant attention as a potential treatment for Inflammatory Bowel Disease (IBD), including both Crohn's disease and Ulcerative Colitis. For systemic healing, consider combining with TB-500. Unlike BPC-157 which heals tissue mechanically, KPV specifically targets the immune-mediated inflammation at the root of IBD. For broader immune system support, thymosin alpha-1 targets T-cell function and chronic immune resilience.